Protocol | Dose | Infection rate | Pre-patent (days) | % parasitaemia day 3 | % parasitaemia range on Day 7 | % peak parasitaemia |
---|---|---|---|---|---|---|
Post-Infection per oral treatment | IC | 100 % | 2–3 | 3.70 ± 0.675 | 15.7 ± 3.264 | 69.3 ± 3.88 |
30CHQ | 100 % | 2–3 | 1.167 ± 0.307 | 16.1 ± 1.325 | 43.3 ± 1.66 | |
5AA | 100 % | 2–3 | 1.928 ± 0.778 | 16.9 ± 2.774 | 41.7 ± 4.51* | |
10AA | 100 % | 2–3 | 3.230 ± 2.209 | 21.3 ± 3.608*# | 27.7 ± 1.96*# | |
20AA | 100 % | 2–3 | 1.815 ± 1.016 | 8.4 ± 3.848*# | 46.2 ± 2.94* |